Markers of airway inflammation in pulmonary diseases assessed by induced sputum

Submitted: January 21, 2016
Accepted: January 21, 2016
Published: January 21, 2016
Abstract Views: 1061
PDF: 549
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

During recent years there has been a growing interest in using non-invasive biomarkers to understand and monitor the airway inflammation in subjects with respiratory tract disorders. To date, the best validated and performing non-invasive biomarkers are measures of inflammation in induced sputum in both cellular and fluid phase, which can provide biological insights into the pathogenesis of respiratory diseases such as asthma and chronic obstructive pulmonary disease. The purpose of this review is to examine the principal literature on the different markers of inflammation in pulmonary diseases assessed by induced sputum analysis in either cellular or fluid phase.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Dragonieri, S., O. Tongoussouva, A. Zanini, A. Imperatori, and A. Spanevello. 2016. “Markers of Airway Inflammation in Pulmonary Diseases Assessed by Induced Sputum”. Monaldi Archives for Chest Disease 71 (3). https://doi.org/10.4081/monaldi.2009.357.

Similar Articles

<< < 14 15 16 17 18 19 20 > >> 

You may also start an advanced similarity search for this article.